Iloperidone for Uncontrolled Hypertension

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Recruiting Phase 2 Interventional Study
Hypertension Uncontrolled Hypertension
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
240 (estimated)
Sponsor
Vanda Pharmaceuticals · Industry
Who this trial is looking for

This trial is looking for people with uncontrolled high blood pressure. Participants will take either the study drug or a placebo to see if it helps lower their blood pressure.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have high blood pressure of 130 mmHg or higher despite treatment

You may not be able to join if

  • I have severe high blood pressure (180 mmHg or higher)
  • I have unstable heart disease
  • I have kidney problems

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * SiSBP \>/= 130 mmHg despite \>8 weeks treatment w/ 1 or more antihypertensive therapies Exclusion Criteria: * Confirmed Grade 3/severe hypertension (SiSBP \>/= 180 mmHg, SiDBP \>/= 120 mmHg), unstable cardiac disease, renal insufficiency
Contacts

Vanda Pharmaceuticals, Inc.

202-734-3400

clinicaltrials@vandapharma.com

CONTACT